Chapter 57. Metabolic Evaluation and Prevention of Renal Stone Disease

  1. Donald A. Molony MD4,5 and
  2. Jonathan C. Craig MD, PhD6,7
  1. David S. Goldfarb MD Professor of Medicine and Physiology1,2,3

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch57

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Goldfarb, D. S. (2008) Metabolic Evaluation and Prevention of Renal Stone Disease, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch57

Editor Information

  1. 4

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 5

    Houston Medical School, Houston, Texas, USA

  3. 6

    School of Public Health, University of Sydney, Australia

  4. 7

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. 1

    Nephrology Section, New York Harbor VA Medical Center, USA

  2. 2

    Department of Urology, St. Vincent's Hospital, USA

  3. 3

    New York University School of Medicine, New York, USA

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • kidney stone disease;
  • Guidelines on evaluation and management of stone formers;
  • evaluation of stone formers;
  • prevention of calcium stones;
  • nonspecific prevention of stone recurrence;
  • calcium phosphate stones;
  • uric acid stones;
  • Cystinuria


This chapter contains sections titled:

  • Introduction

  • Urologic aspects of stone disease

  • Guidelines on evaluation and management of stone formers

  • Evaluation of stone formers

  • Calcium stones

  • Nonspecific prevention of stone recurrence

  • Calcium phosphate stones

  • Struvite stones

  • Uric acid stones

  • Cystinuria

  • References